Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease
Clinical trial NCT00706849 · COMPLETED
Trial details
- NCT number
- NCT00706849
- Sponsor
- Kastle Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-12-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.